Published 2024-03-01
“…Anders Møller,1,2 Nikolaj Eldrup,3– 5 Jørn Wetterslev,6 Dorthe Hellemann,1,5
Henning Bay Nielsen,7,
8 Klaus Rostgaard,9,10 Henrik Hjalgrim,5,9– 11,* Ole Birger Pedersen5,10,12,* 1Department of Anesthesia and Intensive Care, Næstved-Slagelse-Ringsted, Slagelse Hospital, Slagelse, Denmark; 2Department of Anaesthesia and Intensive Care, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark; 3Department of Vascular Surgery, Rigshospitalet, Copenhagen, Denmark; 4Danish Vascular Registry, Aarhus, Denmark; 5Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 6Private Office, Tuborg Sundpark, Hellerup, 2900, Denmark; 7Department of Anesthesia and Intensive Care, Zealand University Hospital Roskilde, Roskilde, Denmark;
8Department of Nutrition, Exercise and Sport, Faculty of Science, University of Copenhagen, Copenhagen, Denmark; 9Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark; 10Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; 11Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark; 12Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark*These authors contributed equally to this workCorrespondence: Anders Møller, Department of Anesthesia and Intensive Care, Næstved-Slagelse-Ringsted Hospital, Fælledvej 11, Slagelse, DK-4200, Denmark, Tel +45 58 55 92 02, Email dr.andersm@gmail.comBackground: The prevalence of occlusive lower extremity artery disease (LEAD) is rising worldwide while European epidemiology data are scarce. …”
Get full text
Article